Epigenetic alteration of Wnt pathway antagonists in progressive glandular neoplasia of the lung
Epigenetic alteration of Wnt pathway antagonists in progressive glandular neoplasia of the lung
复制标题
DOI:
10.1093/carcin/bgn017
复制
发表时间:
2008-05-01
期刊:
影响因子:
4.7
通讯作者:
Herman, James G.
中科院分区:
文献类型:
--
作者:
Licchesi, Julien D. F.;Westra, William H.;Herman, James G.
Background: Atypical adenomatous hyperplasia (AAH) is now recognized as a precursor lesion from which lung adenocarcinomas arise and thus represents an ideal target for studying the early genetic and epigenetic alterations associated with lung tumorigenesis such as alterations of the Wnt pathway. Methods: We assessed the level of Wnt signaling activity in lung cancer cell lines by determining the level of active beta-catenin and determined the level of expression of Wnt antagonists APC, DKK1, DKK3, LKB1, SFRP1, 2, 4, 5, WIF1 and RUNX3 using reverse transcription polymerase chain reaction. Using multiplex nested methylation-specific polymerase chain reaction, we analyzed promoter region methylation of these genes in resected lung tissue in the histopathologic sequence of glandular neoplasia ( normal lung parenchyma, low-grade and high-grade AAH, adenocarcinoma). Results: The majority of non-small cell lung cancer cell lines ( 11 of 16, 69%) have evidence of active Wnt signaling and silencing of Wnt antagonists correlated with promoter hypermethylation. Promoter region methylation of Wnt antagonists was common in primary lung adenocarcinoma and there was a significant increase in the frequency of methylation for Wnt antagonist genes and the number of genes methylated with each stage of tumorigenesis ( test for rend P